CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Alector shares up after sealing $1.27bn Roche Parkinson’s disease license deal

PartnershipPositive
AI Analysis

Summary

Alector sealed a $1.27 billion license deal with Roche for a Parkinson's disease treatment, resulting in a positive share price movement for Alector.

Outcome Details

$1.27 billion license deal

Importance:7/10
Sentiment:
0.80
licensingpartnershipParkinson's diseasedeal
Related Companies

Read the original article

Published by yahoo_finance on October 6, 2026 10:59 AM

Read Original